Dmitriy Genkin
Président chez PHARMSYNTHEZ
Fortune : 258 520 $ au 30/04/2024
Profil
Dmitriy Dmitrievich Genkin is the founder of Santersus AG.
He currently holds multiple positions including Executive Chairman at Pharmsynthez PJSC, Director & Partner at FDS Pharma Associates Ltd., Director at Kevelt AS, Managing Director at FDS Pharma LLP, Director at SynBio LLC, Non-Executive Director at Xenetic Biosciences, Inc., Director at Peri-Ness Technologies Ltd., Director at CLS Therapeutics, Inc., and Member-Supervisory Board at EPhaG AS.
In the past, he served as a Director at Xenetic Biosciences (UK) Ltd.
from 2000 to 2013, Non-Executive Director at Artgen Biotech PJSC from 2009 to 2011, Non-Executive Director at Xenetic Biosciences, Inc. from 2017 to 2021, and Non-Executive Director at Xenetic Biosciences, Inc. from 2004 to 2016.
He also has a background in academia as a Professor at University College London.
He completed his undergraduate degree at Mechnikov St Petersburg State Medical Academy and obtained undergraduate and graduate degrees from The School of Pharmacy University of London in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 68 464 ( 4,44% ) | 258 520 $ | 30/04/2024 |
Postes actifs de Dmitriy Genkin
| Sociétés | Poste | Début |
|---|---|---|
| PHARMSYNTHEZ | Président | 01/01/2005 |
| XENETIC BIOSCIENCES, INC. | Directeur/Membre du Conseil | - |
Peri-Ness Technologies Ltd.
 Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Directeur/Membre du Conseil | - |
SANTERSUS AG
 SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Fondateur | - |
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Directeur/Membre du Conseil | 01/01/2011 |
Kevelt AS
 Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Directeur/Membre du Conseil | 01/01/2013 |
FDS Pharma LLP
 FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Directeur Général | 01/01/2003 |
EPhaG AS
 EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Directeur/Membre du Conseil | 01/01/2007 |
| FDS Pharma Associates Ltd. | Directeur/Membre du Conseil | 17/11/2010 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Dmitriy Genkin
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Dmitriy Genkin
| Mechnikov St Petersburg State Medical Academy | Undergraduate Degree |
| The School of Pharmacy University of London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HUMAN STEM CELLS INSTITUTE | Health Services |
| PHARMSYNTHEZ | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
| FDS Pharma Associates Ltd. | |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Retail Trade |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Health Technology |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Health Technology |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Health Technology |
| CLS THERAPEUTICS, INC. |